NICE

Share

🐣 SPRING OFFER! Go ad free with NewsNow Essentials at just £2.99/m!

🐣 SPRING OFFER! Stay informed ad free with NewsNow Essentials at just £2.99 a month!

NICE recommends Genmab’s cervical cancer treatment Pharmaceutical Field 21:25 Mon, 25 May

Pharmaceutical Field 21:25 Mon, 25 May

Cervical Cancer Pharma

NICE changes stance on Genmab's cervical cancer drug pharmaphorum 09:58 Fri, 22 May

pharmaphorum 09:58 Fri, 22 May

NHS Cervical Cancer

J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology 2d

Pharmaceutical Technology 2d

Advertisement

Advertisement

GSK’s Nucala secures NICE COPD endorsement Pharmaceutical Technology 12:18 Fri, 29 May

Pharmaceutical Technology 12:18 Fri, 29 May

'Every minute counts when it comes to new ovarian cancer treatment' BBC 7d

BBC 7d

AbbVie's migraine drug cleared for migraine attacks on NHS pharmaphorum 20h

pharmaphorum 20h

Advertisement

Advertisement

Latest

Yesterday

AbbVie's migraine drug cleared for migraine attacks on NHS pharmaphorum 11:57 Wed, 10 Jun

Tuesday

J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology 09:48 Tue, 09 Jun

In the last month

'Every minute counts when it comes to new ovarian cancer treatment' BBC 14:50 Thu, 04 Jun

AbbVie's ovarian cancer drug Elahere gets NHS green light pharmaphorum 09:02 Thu, 04 Jun

British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy The Tribune, California 00:21 Thu, 04 Jun

GSK’s Nucala secures NICE COPD endorsement Pharmaceutical Technology 12:18 Fri, 29 May

NICE recommends Genmab’s Tivdak for recurrent or metastatic cervical cancer PMLiVE 11:05 Thu, 28 May

NICE recommends Genmab’s cervical cancer treatment Pharmaceutical Field 21:25 Mon, 25 May

NICE changes stance on Genmab's cervical cancer drug pharmaphorum 09:58 Fri, 22 May

The US pharma deal is a crime against UK healthcare New Statesman 14:06 Wed, 20 May

Advertisement

Advertisement

Advertisement

Don't miss out! Get the day's top headlines delivered to your inbox

Advertisement

Advertisement